This is under way at a WHO collaborating centre in Latvia where national tuberculosis programme staff are trained in the management of MDR-TB, and a similar centre is being set up in the Philippines.
The drugs for the lengthy treatment of MDR-TB can cost more than 100 times that of the drugs to treat common tuberculosis strains.
用于疗耐多药结核病漫长治疗的药品费用比治疗常见结核病菌株的药品可能贵100倍以上。
3
MDR-TB (Multidrug Resistant TB) describes strains of tuberculosis that are resistant to at least the two main first-line TB drugs - isoniazid and rifampicin.